Hamaguchi R, Isowa M, Narui R, Morikawa H, Okamoto T, Wada H
Biomedicines. 2024; 12(10).
PMID: 39457509
PMC: 11504456.
DOI: 10.3390/biomedicines12102197.
Hamaguchi R, Uemoto S, Wada H
Front Oncol. 2023; 13:1223025.
PMID: 37324021
PMC: 10264763.
DOI: 10.3389/fonc.2023.1223025.
Harguindey S, Reshkin S, Alfarouk K
Cancers (Basel). 2023; 15(2).
PMID: 36672490
PMC: 9856494.
DOI: 10.3390/cancers15020540.
Hamaguchi R, Isowa M, Narui R, Morikawa H, Wada H
Front Oncol. 2022; 12:1003588.
PMID: 36185175
PMC: 9516301.
DOI: 10.3389/fonc.2022.1003588.
Wada H, Hamaguchi R, Narui R, Morikawa H
Front Oncol. 2022; 12:920843.
PMID: 35965526
PMC: 9364696.
DOI: 10.3389/fonc.2022.920843.
Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H-Centered Anticancer Paradigm of the Late Post-Warburg Era.
Harguindey S, Alfarouk K, Polo Orozco J, Fais S, Devesa J
Int J Mol Sci. 2020; 21(20).
PMID: 33050492
PMC: 7589677.
DOI: 10.3390/ijms21207475.
A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.
Harguindey S, Alfarouk K, Polo Orozco J, Hardonniere K, Stanciu D, Fais S
Int J Mol Sci. 2020; 21(3).
PMID: 32046158
PMC: 7036897.
DOI: 10.3390/ijms21031110.
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.
Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N
Oncotarget. 2016; 7(39):63408-63423.
PMID: 27566564
PMC: 5325373.
DOI: 10.18632/oncotarget.11503.
The Function of V-ATPases in Cancer.
Stransky L, Cotter K, Forgac M
Physiol Rev. 2016; 96(3):1071-91.
PMID: 27335445
PMC: 4982037.
DOI: 10.1152/physrev.00035.2015.
Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1.
Arnason T, Harkness T
Cancers (Basel). 2015; 7(4):2063-82.
PMID: 26501324
PMC: 4695877.
DOI: 10.3390/cancers7040877.
Differential remodeling of extracellular matrices by breast cancer initiating cells.
Raja A, Xu S, Zhuo S, Tai D, Sun W, So P
J Biophotonics. 2015; 8(10):804-15.
PMID: 25597396
PMC: 4761427.
DOI: 10.1002/jbio.201400079.
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
Kathawala R, Wei L, Anreddy N, Chen K, Patel A, Alqahtani S
Oncotarget. 2014; 6(1):510-21.
PMID: 25402202
PMC: 4381611.
DOI: 10.18632/oncotarget.2638.
Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.
Fais S, Venturi G, Gatenby B
Cancer Metastasis Rev. 2014; 33(4):1095-108.
PMID: 25376898
PMC: 4244550.
DOI: 10.1007/s10555-014-9531-3.
Masitinib antagonizes ATP-binding cassette subfamily C member 10-mediated paclitaxel resistance: a preclinical study.
Kathawala R, Sodani K, Chen K, Patel A, Abuznait A, Anreddy N
Mol Cancer Ther. 2014; 13(3):714-23.
PMID: 24431074
PMC: 3954439.
DOI: 10.1158/1535-7163.MCT-13-0743.
Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
Harguindey S, Arranz J, Polo Orozco J, Rauch C, Fais S, Cardone R
J Transl Med. 2013; 11:282.
PMID: 24195657
PMC: 3826530.
DOI: 10.1186/1479-5876-11-282.
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.
Peetla C, Vijayaraghavalu S, Labhasetwar V
Adv Drug Deliv Rev. 2013; 65(13-14):1686-98.
PMID: 24055719
PMC: 3840112.
DOI: 10.1016/j.addr.2013.09.004.
Potential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferation.
Aravena C, Beltran A, Cornejo M, Torres V, Diaz E, Guzman-Gutierrez E
PLoS One. 2012; 7(12):e51451.
PMID: 23236503
PMC: 3516555.
DOI: 10.1371/journal.pone.0051451.
Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M, Huang S, Zhang X, Zhang B, Zhu H, Yang V
J Cell Biochem. 2012; 113(7):2474-87.
PMID: 22396185
PMC: 3762681.
DOI: 10.1002/jcb.24122.
Altered intracellular pH regulation in cells with high levels of P-glycoprotein expression.
Young G, Reuss L, Altenberg G
Int J Biochem Mol Biol. 2011; 2(3):219-27.
PMID: 22003434
PMC: 3193293.
Toward a mechanical control of drug delivery. On the relationship between Lipinski's 2nd rule and cytosolic pH changes in doxorubicin resistance levels in cancer cells: a comparison to published data.
Rauch C
Eur Biophys J. 2009; 38(7):829-46.
PMID: 19296096
DOI: 10.1007/s00249-009-0429-x.